Clinical Trials Logo

Cesarean Section; Infection clinical trials

View clinical trials related to Cesarean Section; Infection.

Filter by:

NCT ID: NCT03960970 Recruiting - Wound Infection Clinical Trials

Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries

Start date: September 15, 2019
Phase: Phase 2
Study type: Interventional

Cesarean deliveries are the most common surgical procedure performed in the United States. A significant decrease in cesarean delivery associated maternal morbidity has been achieved with preoperative prophylactic single-dose cephalosporin, widely used before skin incision. Also, on laboring patients and/or with rupture of membranes, several studies suggest that adding azithromycin to standard cephalosporin prophylaxis is cost-effective and reduces overall rates of endometritis, wound infection, readmission, use of antibiotics and serious maternal events. Azithromycin has effective coverage against Ureaplasma, associated with increased rates of endometritis. Although two-drug regimen has been suggested for laboring and/or patients that undergo cesarean delivery, no studies have investigated the potential benefits of two-drug regimen in non-laboring patients.

NCT ID: NCT03838965 Completed - Preeclampsia Clinical Trials

The Effects of Labor Stages and Interventions on Hemodynamic Measures During & After Childbirth With Noninvasive Sensors

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

The Effects of Labor Stages and Interventions on Hemodynamic Measures During and After Childbirth ( Epidural, Rupture Membranses Cesarean Sections and Preeclampsia) With Noninvasive Sensors.

NCT ID: NCT03672214 Not yet recruiting - Clinical trials for Urinary Tract Infections

Caesarean Delivery With or Without an Indwelling Bladder Catheter

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to compare the incidence of catheter associated culture-based urinary tract infection (UTI) after elective CD with or without preoperative placement of a urinary catheter.

NCT ID: NCT03640507 Completed - Clinical trials for Surgical Site Infection

Vaginal Preparation With Chlorhexidine-alcohol vs. Povidine-iodine vs. Saline

Start date: October 1, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to see whether chlorhexidine is superior to povidine-iodine vaginal antisepsis at reducing bacteria colony counts in pregnant women by comparing three groups: vaginal washing with chlorhexidine-alcohol, vaginal washing with povidine-iodine, and vaginal washing with saline alone.

NCT ID: NCT03536832 Completed - Clinical trials for Cesarean Section; Infection

Subcuticular Skin Closure at Cesarean Delivery

Start date: April 15, 2018
Phase: N/A
Study type: Interventional

Subcuticular skin closure with suture after cesarean has been shown to result in lower rates of wound complications than with staple closure. However, the optimal choice of suture material for subcuticular skin closure is unclear. Vicryl vs Prolen suture materials will be used for subcuticular closure of transverse skin incisions after cesarean section. Patients will be controlled for superficial surgical site infections 1 week after the cesarean section.

NCT ID: NCT03500055 Recruiting - Clinical trials for Surgical Site Infection

Abdominal Closure Bundle to Reduce Surgical Site Infection in Patients Undergoing C-sections. Cesarean Section Lead to Reduction in Surgical Site Infection? - A Randomized Controlled Trial

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

This study is a single center, randomized controlled trial investigating the use of an abdominal closure bundle to reduce surgical site infection in patients undergoing cesarean section. The abdominal closure bundle consists of surgeon repeat scrub, changing gown and gloves, as well as usage of new instruments for closure of fascia, subcutaneous tissue, and skin. Patients will be randomized to either abdominal closure bundle or normal operative procedure. Primary outcome is surgical site infection within 30 days of procedure.

NCT ID: NCT03479931 Terminated - Clinical trials for Catheter-Related Infections

Caesarean Delivery With or Without an Indwelling Bladder Catheter. A Randomised Trial.

Start date: February 14, 2018
Phase: N/A
Study type: Interventional

The aim of this study is to compare the incidence of catheter associated culture-based urinary tract infection (UTI) after elective CD with or without preoperative placement of a urinary catheter.

NCT ID: NCT03386240 Recruiting - Clinical trials for Surgical Site Infection

Antibacterial-coated Sutures at Time of Cesarean

ASTC
Start date: January 9, 2018
Phase: Phase 4
Study type: Interventional

Abdominal closure with antibacterial-coated sutures has been shown to reduce wound infections after a number of surgical procedures, but none of the previous trials included cesarean delivery. Our objective is to determine whether use of antibacterial-coated sutures reduces surgical site infection (SSI) after cesarean delivery.

NCT ID: NCT03284749 Completed - Clinical trials for Surgical Site Infection

Effect of Copper on the Healing of Obstetric Wounds

ECHO
Start date: January 14, 2016
Phase: N/A
Study type: Interventional

The most common complication of vaginal delivery is perineal tearing with a prevalence of 85% and 70% will need suturing. The caesarean section rate worldwide is rising and the rate in Croydon University Hospital is in the region of 25% of all deliveries. One in ten women will develop a wound infection of their perineal tear or caesarean section wound. Wound infection can cause pain, dehiscence, delayed wound healing, prolonged hospital stay, readmissions and interfere with a woman's ability to nurture their baby and enjoy motherhood. Copper has shown to have strong antimicrobial properties, with the ability to kill various bacteria including MRSA. It has also been shown that copper promotes new blood vessel formation and therefore enhance wound healing. This study is to investigate the effect of copper impregnated dressings and maternity pads on wound infection. Women will be randomised for a wound dressing or maternity pad with (study group) or without copper (control group). Both the clinician and the woman will be blinded to the randomised group. Wound infection will be assessed via a telephone questionnaire after 7, 14 and 30 days after delivery. When wound infection is suspected, based on the questionnaire, a swab of the wound site will be taken to detect the causative bacteria.